Eli Lilly



Ebitda تغيير تاريخ
AbbVie USD 6.92B 258M 2024-12
Abbott USD 2.18B 486M 2025-03
ALKERMES USD 21.21M 142.21M 2025-03
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Baxter International USD 576M 116M 2024-12
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Drreddys Laboratories INR 23.31B 1.4B 2024-12
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Indivior 72M 34M 2025-03
J&J USD 7.88B 1.76B 2025-03
Medtronic USD 2.7B 267M 2025-04
Merck USD 7.74B 625M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Novo Nordisk 42.62B 6.65B 2025-03
Perrigo USD 245.1M 49.4M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Prestige Brands USD 108.15M 9.32M 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Sanofi EUR 563M 3.93B 2024-12
United Therapeutics USD 402.6M 19.2M 2025-03
Zoetis USD 968M 74M 2025-03



Eli Lilly - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.